1. The Emerging Role of Long Non-Coding RNAs in Esophageal Cancer: Functions in Tumorigenesis and Clinical Implications
   Yali Han et al, 2022, Frontiers in Pharmacology CrossRef
2. The Involvement of Long Non-Coding RNAs in Bone
   Cinzia Aurilia et al, 2021, International Journal of Molecular Sciences CrossRef
3. Circulating Long Non-Coding RNAs as Novel Potential Biomarkers for Osteogenic Sarcoma
   Sutpirat Moonmuang et al, 2021, Cancers CrossRef
4. Total Glucosides of Paeony Inhibited Autophagy and Improved Acute Kidney Injury Induced by Ischemia-Reperfusion via the lncRNA TUG1/miR-29a/PTEN Axis
   Xiaoyan Chang et al, 2021, Drug Design, Development and Therapy CrossRef
5. Long Non-Coding RNAs as Competitive Endogenous RNAs in Osteosarcoma
   N. E. Kushlinskii et al, 2020, Molecular Biology CrossRef
6. Selection of lncRNAs That Influence the Prognosis of Osteosarcoma Based on Copy Number Variation Data
   Jian Zhang et al, 2022, Journal of Oncology CrossRef
7. RUNX2 as a promising therapeutic target for malignant tumors
   Weizhu Zhao et al, 2021, Cancer Management and Research CrossRef
8. Oncogenic Dysregulation of Circulating Noncoding RNAs: Novel Challenges and Opportunities in Sarcoma Diagnosis and Treatment
   Lidia Chellini et al, 2022, Cancers CrossRef
9. Serum-Based lncRNA ANRIL, TUG1, UCA1, and HIT Expressions in Breast Cancer Patients
   Ali G. Alkhathami et al, 2022, Disease Markers CrossRef
10. Discovery of New Therapeutic Targets for Osteosarcoma Treatment Based on Immune-Related lncRNAs in the Tumor Microenvironment
    Ribin Fu et al, 2022, BioMed Research International CrossRef
11. Preoperative Predictors of Early Mortality Risk in People with Osteosarcoma of the Extremities Treated with Standard Therapy
    Ke Tian et al, 2022, Cancer Management and Research CrossRef
12. LncRNA-TUG1 promotes the progression of infantile hemangioma by regulating miR-137/IGFBP5 axis
    Lili Zhou et al, 2021, Human Genomics CrossRef